Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

PDMR Dealing

4 Jun 2020 10:28

RNS Number : 9740O
Gresham Technologies PLC
04 June 2020
 

RNS

 

04 June 2020

Gresham Technologies plc

PDMR Dealing

Gresham Technologies plc (LSE: "GHT", "Gresham"), the leading software and services company that specialises in providing solutions for data integrity and control, banking integration, payments and cash management, announces that the following purchases of ordinary shares were made by Ken Archer, a PDMR of the Company by way of an automatic reinvestment of dividends received as part of the Company's dividend reinvestment plan.

Name

Number of Shares Purchased

Total Shares held

Percentage of Issued Share Capital held

Ken Archer

891

150,891

0.2%

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Enquiries

Gresham Technologies plc

+44 (0) 207 653 0200

Ian Manocha

 

Tom Mullan

 

 

 

N+1 Singer (Financial Adviser and Broker)

+44 (0) 207 496 3000

Shaun Dobson / Iqra Amin (Corporate Finance)

 

Tom Salvesen (Corporate Broking)

 

 

 

Note to editors

Gresham Technologies plc is a leading software and services company that specialises in providing real-time solutions for data integrity and control, banking integration, payments and cash management. Listed on the main market of the London Stock Exchange (GHT.L) and headquartered in the City of London, its customers include some of the world's largest financial institutions and corporates, all of whom are served locally from offices located in the UK, Europe, North America and Asia Pacific.

Gresham's award-winning Clareti software platform is a highly flexible and scalable platform, available on-site or in the cloud, designed to address today's most challenging financial control, risk management, data governance and regulatory compliance problems. Learn more at www.greshamtech.com.

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Ken Archer

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gresham Technologies plc

b)

LEI

213800F71LW7L4Y7QL29

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

 

GB0008808825

 

b)

Nature of the transaction

Purchase

c)

 

Price(s) and volume(s)

 

Price

Volume

£1.2435

891

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

n/a - single transaction

 

e)

Date of the transaction

21 May 2020

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFIFFAREISIII
Date   Source Headline
23rd Dec 20202:00 pmRNSSignificant Clareti Contract Win with Global Bank
11th Dec 20207:00 amRNSNotice of General Meeting and Circular
3rd Dec 202012:37 pmRNSExercise of Options
23rd Nov 20207:00 amRNSSignificant Clareti Contract with Global Bank
2nd Nov 20202:17 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSTrading Update
15th Oct 20207:00 amRNSExercise of Options
12th Oct 20207:00 amRNSBoard Changes
5th Oct 20207:00 amRNSExercise of Options
23rd Sep 202012:24 pmRNSExercise of Options
15th Sep 20205:04 pmRNSHolding(s) in Company
30th Jul 202012:28 pmRNSChairman designate dealing
29th Jul 20207:00 amRNSAcquisition of Inforalgo Information Technology
28th Jul 20204:35 pmRNSHolding(s) in Company
28th Jul 20201:34 pmRNSHolding(s) in Company
21st Jul 20207:01 amRNSBoard Changes
21st Jul 20207:00 amRNSHalf-year Report
16th Jul 20207:00 amRNSNotice of Interim Results and Presentations
6th Jul 20201:42 pmRNSHolding(s) in Company
6th Jul 20201:40 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSTrading Update
11th Jun 20203:21 pmRNSHolding(s) in Company
10th Jun 202012:00 pmRNSSignificant Clareti Contract Win with Global Bank
4th Jun 202010:28 amRNSPDMR Dealing
19th May 20201:03 pmRNSHolding(s) in Company
14th May 202012:23 pmRNSResult of AGM
14th May 20207:00 amRNSAGM Statement
6th May 20207:00 amRNSAGM Change of Location
20th Apr 20207:00 amRNSTrading Update – COVID-19 Impact
2nd Apr 20207:00 amRNSNotice of AGM and Dividend Timetable
31st Mar 20207:00 amRNSDirectors Share Awards
27th Mar 20201:33 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20201:58 pmRNSUpdate on Private Investor Presentation
4th Mar 20207:00 amRNSNotice of Results & Analyst Presentation
3rd Feb 20207:00 amRNSElectronic Communications
28th Jan 20203:13 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSTrading Update
3rd Jan 20201:27 pmRNSHolding(s) in Company
27th Dec 20192:55 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSClareti Contract Win and Trading Update
25th Sep 20197:00 amRNSExercise of Options
20th Sep 20197:00 amRNSGresham and ANZ partnership
2nd Sep 201911:11 amRNSHolding(s) in Company
2nd Aug 20195:46 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNotice of Results & Analyst Presentation
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSStrategic fintech partner signs Clareti agreement
5th Jun 20199:56 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.